BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,321,000 | -70.0% | 156,355 | -63.3% | 6.56% | +14.2% |
| Q3 2019 | $17,764,000 | -5.6% | 425,794 | -0.9% | 5.74% | +8.0% |
| Q2 2019 | $18,816,000 | -29.5% | 429,690 | -17.1% | 5.32% | -44.6% |
| Q1 2019 | $26,690,000 | -15.7% | 518,560 | -39.4% | 9.59% | -34.0% |
| Q4 2018 | $31,651,000 | -1.0% | 855,900 | +0.6% | 14.53% | +38.6% |
| Q3 2018 | $31,963,000 | -5.0% | 851,200 | 0.0% | 10.48% | -8.6% |
| Q2 2018 | $33,639,000 | +53.4% | 851,200 | 0.0% | 11.47% | +26.1% |
| Q1 2018 | $21,927,000 | +280.8% | 851,200 | +298.8% | 9.09% | +125.2% |
| Q4 2017 | $5,758,000 | – | 213,435 | – | 4.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |